Aspira Women's Health
In Brief This Week:, Thermo Fisher Scientific, Agilent, Labcorp, More
News items for the week of Jan. 9, 2023.
Earnings Roundup: Sera Prognostics, Aspira Women's Health, Immunovia, More
Sera, Aspira, Immunovia, Prenetics, ProPhase Labs, and Devyser reported quarterly financial results this week.
Aspira Women's Health, BioReference Ink Distribution Deal for Ovarian Cancer Test
The Ova1Plus test combines two FDA-approved assays that analyze levels of five biomarkers to provide a malignancy risk index.
Aspira Women's Health Prices $9M Public Offering
The company is offering 12 million shares of common stock along with warrants to purchase 12 million shares.
Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results
All four companies posted net losses for the quarter, while Biodesix's results were hit by a sharp decline in COVID-19 testing revenue.